Site Search
410 result(s) found for “ adaptive therapy”
-
Moffitt Patient Is First To Receive Second CAR T Therapy for Ovarian Cancer
Patient receives second dose of CAR-T immunotherapy for ovarian cancer with special approval from the FDA.
-
Moffitt Researchers Identify Why CAR T Therapy May Fail in Some Lymphoma Patients
Study finds immune dysregulation is associated with poor CAR T-cell expansion and resistance
-
Moffitt Researchers Use Computer Modeling to Predict Patient Tumor Responses to Radiation Therapy
New study finds dynamics between immune effector and suppressor cells can help show how radiation will impact a tumor
-
Moffitt Researchers Use Mathematical Modeling to Analyze Dynamics of CAR T-Cell Therapy
Competition with normal T cells and random extinction events influence patient outcomes
-
New Combo Therapy May Be a Better Option for Patients with Specific Mutation
Adding eprenetapopt to a standard MDS treatment shows promise in patients with TP53 mutations
-
Moffitt Researchers Develop Tool to Measure Patient Health and Well-Being after Radionuclide Therapy
The FACT-RNT tool assesses prostate cancer patient-reported outcomes with the goal of guiding treatment, improving care
-
Moffitt Researchers Show Sequential Treatment with Immunotherapy and Targeted Therapy Prolongs Anti-Tumor Activity
Immunotherapy followed by BRAF and MEK inhibitors promotes anti-tumor immunity and suppresses signaling that leads to drug resistance
-
Newly Approved CAR T-Cell Therapy Gives Acute Lymphoblastic Leukemia a New Personalized Option
Novel design and tumor-guided dosing may reduce side effects while maintaining encouraging efficacy
-
A new type of CAR T called UltraCAR-T™ potentially a therapy for myeloid malignancies
A phase 1b study that was presented at the 2021 American Society of Hematology annual meeting looks at the safety and efficacy of a new type of CAR T...
-
20MA016N: HER-2: Combination Therapy of a HER2-DC1 Dendritic Cell Cancer Vaccine and a Probiotic
HER-2: Combination Therapy of a HER2-DC1 Dendritic Cell Cancer Vaccine FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICEThe...